Skip to content

Effects of Probiotic Capsules in Promoting Fat Excretion by Human Trial

Effects of Grape King Bio Probiotic Capsules in Promoting Fat Excretion by Human Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05607524
Enrollment
60
Registered
2022-11-07
Start date
2022-09-29
Completion date
2023-01-16
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The purpose of this study was to evaluate the efficacy of 2 capsules (500 mg per capsule, 1000 mg per day) of Grape King Probiotic Capsules per day in promoting fat excretion in obese patients by clinical human food test.

Detailed description

This experiment is carried out in a controlled manner. Before the subjects enter the research experiment, they need to follow their original lifestyle. The habits of maintaining a constant body weight for more than 2 weeks before the test, such as calorie balance in the diet and the amount of activity. Then enter the test to carry out the evaluation test of probiotics to the end. 60 subjects were randomized, 20 to placebo and 40 to probiotics. The subjects took two capsules of Grape King probiotics daily, a total of 1000 mg. Continue to take it for 4 weeks, and perform blood routine tests. Body composition detection, waist and hip circumference measurement, related index analysis and 24-hour dietary questionnaires, gut health questionnaires and stool samples were collected and analyzed for 4 weeks before and after treatment.

Interventions

DIETARY_SUPPLEMENTprobiotics

Eat a capsule for once, and twice a day

DIETARY_SUPPLEMENTplacebo

Eat a capsule for once, and twice a day

Sponsors

Grape King Bio Ltd.
CollaboratorINDUSTRY
Chung Shan Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* male or female participants * aged 20-40 years old * body mass index in 25-27 kg/m2 * body fat \> 25% for men and \> 30% for women

Exclusion criteria

* cancer, chronic heart disease, use drugs which pharmacological effects may affect immunity * having systemic infections * using probiotics.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline fecel lipid weight at week 4Week0, Week4Compared the difference of fecel lipid weight level between the week 4 and 0

Countries

Taiwan

Contacts

Primary ContactChin-Lin Hsu, Professor
clhsu@csmu.edu.tw04-24730022

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026